PubMed ID:
36711803
Public Release Type:
Journal
Publication Year: 2023
DOI:
https://doi.org/10.21203/rs.3.rs-2492725/v1
Authors:
Sanyal Arun, Shankar Sudha, Yates Katherine, Bolognese James, Daly Erica, Dehn Clayton, Neuschwander-Tetri Brent, Kowdley Kris, Vuppalanchi Raj, Behling Cynthia A., Tonascia James, Samir Anthony, Sirlin Claude, Sherlock Sarah, Fowler Kathryn, Heymann Helen, Kamphaus Tania, Loomba Rohit, Calle Roberto
Request IDs:
21167
,
21177
,
21318
,
21668
,
21721
,
22939
,
22935
,
22936
,
22937
,
22938
,
23122
,
23382
Studies:
The Farnesoid X Receptor Ligand Obeticholic Acid in NASH Treatment
There are no approved noninvasive tests (NIT) for the diagnosis of nonalcoholic steatohepatitis (NASH) and its histological phenotypes.